Read

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Read, watch, listen
Read

Explore what's trending at Prime

https://www.primetherapeutics.com/w/a-new-era-in-liver-health-how-glp-1s-are-a-mash-treatment-breakthrough Example Link

GLP-1, Stories

A new era in liver health: How GLP-1s are a MASH treatment breakthrough

August 21, 2025

https://www.primetherapeutics.com/w/trending-topics-drug-approvals-august-2025 /trending-topics-drug-approvals-august-2025

Research & Publications

GLP-1 Pipeline Update: August 2025

August 28, 2025

https://www.primetherapeutics.com/w/prime-presents-at-national-association-of-specialty-pharmacy-nasp-annual-meeting-from-sept-14-17

Events

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

August 25, 2025

The Latest

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/prime-therapeutics-leading-research-shows-only-1-in-12-remain-on-a-glp-1-drug-for-obesity-at-three-years

Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

June 25, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-highlights-industry-leading-glp-1-research-at-amcp-2025

Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

March 31, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-glp-1-research-year-2-cost-of-care-is-4-200-higher-for-patients-with-obesity

Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

October 24, 2024

https://www.primetherapeutics.com/w/medical-benefit-drug-trend-prime-therapeutics-medical-pharmacy-trend-report-goes-behind-the-numbers-2024

Medical benefit drug trend: Prime Therapeutics Medical Pharmacy Trend Report™ goes behind the numbers

October 15, 2024

https://www.primetherapeutics.com/w/prime-therapeutics-bolsters-its-position-as-industry-leader-with-10-research-studies-at-amcp-nexus-2024

Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024

October 10, 2024

https://www.primetherapeutics.com/w/prime-therapeutics-announces-new-cost-effective-humira-biosimilar-solutions-offering-clients-flexibility-and-choice

Prime Therapeutics announces new, cost-effective Humira® biosimilar solutions, offering clients flexibility and choice

October 07, 2024

Showing 1 to 6 of 36

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/prime-s-biosimilar-strategy-drives-optionality-for-health-plans

Prime’s biosimilar strategy drives optionality for health plans

August 07, 2025

https://www.primetherapeutics.com/w/prime-refines-the-way-it-serves-medicare-clients-and-members

Prime refines the way it serves Medicare clients and members

July 29, 2025

https://www.primetherapeutics.com/w/what-s-next-in-the-glp-1-pipeline-prime-s-clinical-team-shares-the-latest

What’s next in the GLP-1 pipeline? Prime’s clinical team shares the latest

June 18, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-recognizes-migraine-and-headache-awareness-month

Prime Therapeutics recognizes Migraine and Headache Awareness Month

June 18, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-identifies-addresses-misuse-of-asthma-inhaler-prescription-with-174k-impact

Prime Therapeutics identifies, addresses misuse of asthma inhaler prescription with $174K impact

April 29, 2025

https://www.primetherapeutics.com/w/national-drug-take-back-day-prioritizing-drug-safety-at-home

National Drug Take Back Day: Prioritizing drug safety at home

April 23, 2025

Showing 1 to 6 of 61

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/a-new-era-in-liver-health-how-glp-1s-are-a-mash-treatment-breakthrough

A new era in liver health: How GLP-1s are a MASH treatment breakthrough

August 21, 2025

https://www.primetherapeutics.com/w/innovation-and-impact-mesc-2025-charts-the-future-of-medicaid-technology

Innovation and impact: MESC 2025 charts the future of Medicaid technology

August 21, 2025

https://www.primetherapeutics.com/w/rising-cancer-rates-in-younger-adults-what-health-care-payers-need-to-know

Rising cancer rates in younger adults — what health care payers need to know

August 19, 2025

https://www.primetherapeutics.com/w/what-you-need-to-know-about-the-new-indication-of-a-glp-1-drug-for-mash-therapy

What you need to know about the new indication of a GLP-1 drug for MASH therapy

August 15, 2025

https://www.primetherapeutics.com/w/prime-careers-spotlight-august-2025 /prime-careers-spotlight-august-2025

Prime Careers Spotlight: August 2025

August 15, 2025

https://www.primetherapeutics.com/w/how-prime-builds-an-empowering-workplace-culture

How Prime Therapeutics builds an empowering workplace culture

August 13, 2025

Showing 1 to 6 of 138

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/prime-presents-at-national-association-of-specialty-pharmacy-nasp-annual-meeting-from-sept-14-17

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

August 25, 2025

https://www.primetherapeutics.com/w/prime-presents-at-isg-digital-business-summit-on-nov-14

Prime presents at ISG Digital Business Summit on Nov. 14

November 05, 2024

https://www.primetherapeutics.com/w/prime-presents-2024-medical-pharmacy-trend-report-webinar

Prime presents 2024 Medical Pharmacy Trend Report webinar on Oct. 24

October 01, 2024

https://www.primetherapeutics.com/w/prime-presents-at-amcp-nexus-2024

Prime presents at AMCP Nexus 2024 on Oct. 14–17

September 30, 2024

https://www.primetherapeutics.com/w/prime-presents-at-medicaid-drug-rebate-program-mdrp-summit-2024-on-sept-23-25

Prime presents at Medicaid Drug Rebate Program (MDRP) Summit 2024 on Sept. 23–25

September 23, 2024

https://www.primetherapeutics.com/w/prime-presents-at-72nd-annual-roy-a-bowers-conference

Prime presents at 72nd Annual Roy A. Bowers Conference on Oct. 22

September 16, 2024

Showing 1 to 6 of 34

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/specialty-pharmacy-continuum-glp-1s-for-everything-balancing-access-with-sustainability https://www.specialtypharmacycontinuum.com/Clinical/Article/08-25/GLP-1s-Potential-New-Uses/77960

Specialty Pharmacy Continuum: ‘GLP-1s for Everything!’: Balancing Access With Sustainability

August 15, 2025

https://www.primetherapeutics.com/w/managed-healthcare-executive-medicare-plans-face-higher-liability-from-cap-on-out-of-pocket-drug-costs https://www.managedhealthcareexecutive.com/view/medicare-plans-face-higher-liability-from-cap-on-out-of-pocket-drug-costs

Managed Healthcare Executive: Medicare Plans Face Higher Liability From Cap on Out-of-Pocket Drug Costs

August 15, 2025

https://www.primetherapeutics.com/w/managed-healthcare-executive-nathan-downhour-of-prime-calls-for-clearer-more-sustainable-pharmacy-benefit-models-pbmi-innovator https://www.managedhealthcareexecutive.com/view/nathan-downhour-of-prime-calls-for-clearer-more-sustainable-pharmacy-benefit-models-pbmi-innovator

Managed Healthcare Executive: Nathan Downhour of Prime Calls for Clearer, More Sustainable Pharmacy Benefit Models | PBMI Innovator

August 07, 2025

https://www.primetherapeutics.com/w/forbes-signs-point-to-possible-future-medicare-coverage-of-obesity-meds-but-challenges-remain https://www.forbes.com/sites/joshuacohen/2025/08/05/signs-point-to-possible-future-medicare-coverage-of-obesity-meds-but-challenges-remain/

Forbes: Signs Point To Possible Future Medicare Coverage Of Obesity Meds, But Challenges Remain

August 06, 2025

https://www.primetherapeutics.com/w/managed-healthcare-executive-nathan-downhour-pharm-d-pbmi-innovator https://www.managedhealthcareexecutive.com/view/nathan-downhour-pharm-d-pbmi-innovator

Managed Healthcare Executive: Nathan Downhour, Pharm.D. | PBMI Innovator

August 01, 2025

https://www.primetherapeutics.com/w/st-paul-pioneer-press-what-s-the-latest-in-remote-work-policies-we-asked-some-of-st-paul-s-largest-employers https://www.twincities.com/2025/07/26/st-paul-employers-remote-work-hybrid-office/

St. Paul Pioneer Press: What’s the latest in remote work policies? We asked some of St. Paul’s largest employers

July 28, 2025

Showing 1 to 6 of 112

Categories

PA Research & Publications

https://www.primetherapeutics.com/w/trending-topics-drug-approvals-august-2025 /trending-topics-drug-approvals-august-2025

GLP-1 Pipeline Update: August 2025

August 28, 2025

https://www.primetherapeutics.com/w/2025-medical-pharmacy-trend-report /2025-medical-pharmacy-trend-report1

2025 Medical Pharmacy Trend Report

August 25, 2025

https://www.primetherapeutics.com/w/oncology-insights-august-2025 /oncology-insights-august-2025

Oncology Insights: August 2025

August 19, 2025

https://www.primetherapeutics.com/w/high-cost-therapy-profile-august-2025 /high-cost-therapy-profile-august-2025

High-Cost Therapy Profile: August 2025

August 15, 2025

https://www.primetherapeutics.com/w/summer-2025-issue-clinical-insights-mash /summer-2025-issue-clinical-insights-mash

Metabolic dysfunction–associated steatohepatitis (MASH)

August 15, 2025

Showing 1 to 6 of 166

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Company

About us
Careers
News
Media

Read - Prime Therapeutics

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

A new era in liver health: How GLP-1s are a MASH treatment breakthrough

Trending Topics & Drug Approvals: August 2025

GLP-1 Pipeline Update: August 2025

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

The Latest

Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

Medical benefit drug trend: Prime Therapeutics Medical Pharmacy Trend Report™ goes behind the numbers

Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024

Prime Therapeutics announces new, cost-effective Humira® biosimilar solutions, offering clients flexibility and choice

Prime’s biosimilar strategy drives optionality for health plans

Prime refines the way it serves Medicare clients and members

What’s next in the GLP-1 pipeline? Prime’s clinical team shares the latest

Prime Therapeutics recognizes Migraine and Headache Awareness Month

Prime Therapeutics identifies, addresses misuse of asthma inhaler prescription with $174K impact

National Drug Take Back Day: Prioritizing drug safety at home

A new era in liver health: How GLP-1s are a MASH treatment breakthrough

Innovation and impact: MESC 2025 charts the future of Medicaid technology

Rising cancer rates in younger adults — what health care payers need to know

What you need to know about the new indication of a GLP-1 drug for MASH therapy

Prime Careers Spotlight: August 2025

How Prime Therapeutics builds an empowering workplace culture

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

Prime presents at ISG Digital Business Summit on Nov. 14

Prime presents 2024 Medical Pharmacy Trend Report webinar on Oct. 24

Prime presents at AMCP Nexus 2024 on Oct. 14–17

Prime presents at Medicaid Drug Rebate Program (MDRP) Summit 2024 on Sept. 23–25

Prime presents at 72nd Annual Roy A. Bowers Conference on Oct. 22

Specialty Pharmacy Continuum: ‘GLP-1s for Everything!’: Balancing Access With Sustainability

Managed Healthcare Executive: Medicare Plans Face Higher Liability From Cap on Out-of-Pocket Drug Costs

Managed Healthcare Executive: Nathan Downhour of Prime Calls for Clearer, More Sustainable Pharmacy Benefit Models | PBMI Innovator

Forbes: Signs Point To Possible Future Medicare Coverage Of Obesity Meds, But Challenges Remain

Managed Healthcare Executive: Nathan Downhour, Pharm.D. | PBMI Innovator

St. Paul Pioneer Press: What’s the latest in remote work policies? We asked some of St. Paul’s largest employers

Trending Topics & Drug Approvals: August 2025

GLP-1 Pipeline Update: August 2025

2025 Medical Pharmacy Trend Report

Oncology Insights: August 2025

High-Cost Therapy Profile: August 2025

Metabolic dysfunction–associated steatohepatitis (MASH)

Login Portals

Compliance / Legal

Company